The Beta Cell Responsiveness to Glucose-Dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes

This study has been completed.

Study NCT00321321. Last updated on October 1, 2008.

Information provided by University Hospital, Gentofte, Copenhagen

Study Type:	Interventional
Study Design:	Non-Randomized, Open Label, Uncontrolled, Single Group Assignment
Condition:	Diabetes Mellitus, Type 2
Intervention:	Drug: Sulfonylurea

Participant Flow

Recruitment Details

Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
May 2006 - March 2007, Outpatient clinic and advertisement

Pre-Assignment Details

Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
none

Reporting Groups

	Description
Sulfonylurea	No text entered.

Participant Flow: Overall Study

	Sulfonylurea
STARTED	12
COMPLETED	12
NOT COMPLETED	0

Baseline Characteristics

Reporting Groups

	Description
Sulfonylurea	No text entered.

Baseline Measures

	Sulfonylurea
Number of Participants [units: participants]	12
Age [units: participants]
<=18 years	0
Between 18 and 65 years	11
>=65 years	1
Age [units: years] Mean ± Standard Deviation	55 ± 7.6
Gender [units: participants]
Female	4
Male	8
Region of Enrollment [units: participants]
Denmark	12

Outcome Measures

1. Primary Outcome Measure: Insulin Secretion

Show these results.

Reported Adverse Events

Adverse event information has not been entered for this trial.

The submission of adverse events information is currently optional and is not mandated under U.S. Federal Law (US Public Law 110-85, Title VIII) until September 27, 2009.

More Information

Certain Agreements:

All Principal Investigators ARE employed by the organization sponsoring the study.

Limitations and Caveats